Optimal vaccine allocation strategy: Theory and application to the early stage of COVID-19 in Japan-Reference-Cited by-同舟云学术

Optimal vaccine allocation strategy: Theory and application to the early stage of COVID-19 in Japan

Published:2024 Issue:6 Volume:21 Page:6359-6371
ISSN:1551-0018
Container-title:Mathematical Biosciences and Engineering
language:
Short-container-title:MBE

Author:

Kuniya Toshikazu¹,Nakata Taisuke²,Fujii Daisuke³

Affiliation:

1. Graduate School of System Informatics, Kobe University, 1-1 Rokkodai-cho, Nada-ku, Kobe 657-8501, Japan

2. Graduate School of Economics and Graduate School of Public Policy, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan

3. Research Institute of Economy, Trade and Industry, 1-3-1, Kasumigaseki Chiyoda-ku, Tokyo 100-8901, Japan

Abstract

<abstract> <p>In this paper, we construct an age-structured epidemic model to analyze the optimal vaccine allocation strategy in an epidemic. We focus on two topics: the first one is the optimal vaccination interval between the first and second doses, and the second one is the optimal vaccine allocation ratio between young and elderly people. On the first topic, we show that the optimal interval tends to become longer as the relative efficacy of the first dose to the second dose (RE) increases. On the second topic, we show that the heterogeneity in the age-dependent susceptibility (HS) affects the optimal allocation ratio between young and elderly people, whereas the heterogeneity in the contact frequency among different age groups (HC) tends to affect the effectiveness of the vaccination campaign. A counterfactual simulation suggests that the epidemic wave in the summer of 2021 in Japan could have been greatly mitigated if the optimal vaccine allocation strategy had been taken.</p> </abstract>

Publisher

American Institute of Mathematical Sciences (AIMS)

Reference18 articles.

1. S. Flaxman, S. Mishra, A. Gandy, H. J. T. Unwin, T. A. Mellan, H. Coupland, et al., Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe, Nature, 584 (2020), 257–261. https://doi.org/10.1038/s41586-020-2405-7

2. M. Nicola, Z. Alsafi, C. Sohrabi, A. Kerwan, A. Al-Jabir, C. Iosifidis, et al., The socio-economic implications of the coronavirus pandemic (COVID-19): A review, Int. J. Surgery, 78 (2020), 185–193. https://doi.org/10.1016%2Fj.ijsu.2020.04.018

3. World Health Organization, WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines in the context of limited supply, 2020. Available from: https://www.who.int/docs/default-source/immunization/sage/covid/sage-prioritization-roadmap-covid19-vaccines.pdf.

4. Joint Committee on Vaccination and Immunisation, Prioritising the first COVID-19 vaccine dose: JCVI statement, 2021. Available from: https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement.

5. L. S. Ferreira, O. Canton, R. L. P. Silva, S. Poloni, V. Sudbrack, M. E. Borges, et al., Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2, PLoS Comput. Biol., 18 (2022), e10009978. https://doi.org/10.1371/journal.pcbi.1009978

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 risk perceptions in Japan: a cross-sectional study;Scientific Reports;2024-07-23